SK3298A3 - Use of ipriflavone to reduce the number of cd8+ cells - Google Patents
Use of ipriflavone to reduce the number of cd8+ cells Download PDFInfo
- Publication number
- SK3298A3 SK3298A3 SK32-98A SK3298A SK3298A3 SK 3298 A3 SK3298 A3 SK 3298A3 SK 3298 A SK3298 A SK 3298A SK 3298 A3 SK3298 A3 SK 3298A3
- Authority
- SK
- Slovakia
- Prior art keywords
- cells
- isopropoxyisoflavone
- ipriflavone
- cytotoxic
- admixture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9502198A HU9502198D0 (en) | 1995-07-21 | 1995-07-21 | Novel indication |
| PCT/HU1996/000038 WO1997003664A1 (en) | 1995-07-21 | 1996-07-16 | Use of ipriflavone to reduce the number of cd8+ cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK3298A3 true SK3298A3 (en) | 1998-07-08 |
Family
ID=10987063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK32-98A SK3298A3 (en) | 1995-07-21 | 1996-07-16 | Use of ipriflavone to reduce the number of cd8+ cells |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0841915A1 (cs) |
| JP (1) | JP2001503371A (cs) |
| KR (1) | KR19990028933A (cs) |
| CN (1) | CN1191483A (cs) |
| AR (1) | AR002905A1 (cs) |
| AU (1) | AU6367096A (cs) |
| BG (1) | BG102182A (cs) |
| BR (1) | BR9610187A (cs) |
| CA (1) | CA2227421A1 (cs) |
| CZ (1) | CZ2798A3 (cs) |
| EA (1) | EA199800146A1 (cs) |
| EE (1) | EE9800020A (cs) |
| HR (1) | HRP960345A2 (cs) |
| HU (1) | HU9502198D0 (cs) |
| IL (1) | IL122751A0 (cs) |
| MX (1) | MX9800603A (cs) |
| NO (1) | NO980127L (cs) |
| PL (1) | PL324460A1 (cs) |
| SK (1) | SK3298A3 (cs) |
| WO (1) | WO1997003664A1 (cs) |
| YU (1) | YU42796A (cs) |
| ZA (1) | ZA966079B (cs) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1241079B (it) * | 1990-03-23 | 1993-12-29 | Chiesi Farma Spa | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico |
| HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
-
1995
- 1995-07-21 HU HU9502198A patent/HU9502198D0/hu unknown
-
1996
- 1996-07-16 CZ CZ9827A patent/CZ2798A3/cs unknown
- 1996-07-16 WO PCT/HU1996/000038 patent/WO1997003664A1/en not_active Application Discontinuation
- 1996-07-16 BR BR9610187A patent/BR9610187A/pt not_active Application Discontinuation
- 1996-07-16 IL IL12275196A patent/IL122751A0/xx unknown
- 1996-07-16 CN CN96195722A patent/CN1191483A/zh active Pending
- 1996-07-16 JP JP50646497A patent/JP2001503371A/ja active Pending
- 1996-07-16 AU AU63670/96A patent/AU6367096A/en not_active Abandoned
- 1996-07-16 KR KR1019980700235A patent/KR19990028933A/ko not_active Withdrawn
- 1996-07-16 EP EP96923004A patent/EP0841915A1/en not_active Withdrawn
- 1996-07-16 EA EA199800146A patent/EA199800146A1/ru unknown
- 1996-07-16 EE EE9800020A patent/EE9800020A/xx unknown
- 1996-07-16 MX MX9800603A patent/MX9800603A/es unknown
- 1996-07-16 CA CA002227421A patent/CA2227421A1/en not_active Abandoned
- 1996-07-16 PL PL96324460A patent/PL324460A1/xx unknown
- 1996-07-16 SK SK32-98A patent/SK3298A3/sk unknown
- 1996-07-17 ZA ZA9606079A patent/ZA966079B/xx unknown
- 1996-07-18 HR HRP9502198A patent/HRP960345A2/hr not_active Application Discontinuation
- 1996-07-19 YU YU42796A patent/YU42796A/sh unknown
- 1996-07-22 AR ARP960103677A patent/AR002905A1/es unknown
-
1998
- 1998-01-12 NO NO980127A patent/NO980127L/no unknown
- 1998-01-14 BG BG102182A patent/BG102182A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL122751A0 (en) | 1998-08-16 |
| BR9610187A (pt) | 1998-07-28 |
| EP0841915A1 (en) | 1998-05-20 |
| CN1191483A (zh) | 1998-08-26 |
| AU6367096A (en) | 1997-02-18 |
| CZ2798A3 (cs) | 1998-06-17 |
| NO980127D0 (no) | 1998-01-12 |
| KR19990028933A (ko) | 1999-04-15 |
| HU9502198D0 (en) | 1995-09-28 |
| WO1997003664A8 (en) | 1999-08-05 |
| EE9800020A (et) | 1998-08-17 |
| PL324460A1 (en) | 1998-05-25 |
| NO980127L (no) | 1998-01-12 |
| ZA966079B (en) | 1998-01-19 |
| WO1997003664A1 (en) | 1997-02-06 |
| EA199800146A1 (ru) | 1998-08-27 |
| AR002905A1 (es) | 1998-04-29 |
| CA2227421A1 (en) | 1997-02-06 |
| JP2001503371A (ja) | 2001-03-13 |
| BG102182A (bg) | 1998-08-31 |
| MX9800603A (es) | 1998-04-30 |
| HRP960345A2 (en) | 1998-02-28 |
| YU42796A (sh) | 1999-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3260378B2 (ja) | 腸感染に対する薬物の調製のためのフマギロールおよびその誘導体の使用 | |
| KR0164435B1 (ko) | 비만증 치료용 약제학적 조성물 | |
| JP2019123738A (ja) | ジアルキルフマレート含有薬剤調合物 | |
| US5792476A (en) | Sustained release glucocorticoid pharmaceutical composition | |
| EP1976516A2 (en) | Viral hepatitis treatment | |
| Sullivan et al. | Lamotrigine‐induced toxic epidermal necrolysis treated with intravenous cyclosporin: a discussion of pathogenesis and immunosuppressive management | |
| KR100424503B1 (ko) | 암전이억제제 | |
| RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
| WO1991002529A2 (en) | Product and method for killing abnormal vertebrate cells | |
| JP2706371B2 (ja) | 癌治療用補助剤及びそれを用いたキット | |
| JPH0489428A (ja) | 多形核白血球活性化剤 | |
| DE69124380T2 (de) | Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten | |
| SK3298A3 (en) | Use of ipriflavone to reduce the number of cd8+ cells | |
| Hinterberger-Fischer et al. | Coincidence of severe aplastic anaemia with multiple sclerosis or thyroid disorders: report of 5 cases | |
| WO2019072014A1 (zh) | 含A-失碳-5α雄甾烷化合物的升白制剂及其应用 | |
| WO1997005896B1 (en) | Combined use of interleukin-10 and cyclosporin for immunosuppression therapy | |
| JPH06135836A (ja) | コントラサプレッサー細胞の誘導剤 | |
| US6306901B1 (en) | Agent for prophylaxis and therapy of diseases | |
| GB2189703A (en) | Vinpocetine | |
| US3679793A (en) | Method of raising the white blood cell count | |
| WO2014182944A1 (en) | Compositions and method for treatment of ischemic neuronal reperfusion injury | |
| DE2215728A1 (de) | Arzneimittel zur behandlung von herpes simplex | |
| MXPA98000603A (en) | Use of ipriflavona to reduce the number of cells c | |
| EP0005074A1 (en) | A material and composition for reducing blood pressure | |
| EP0347927A2 (de) | Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on (Ebselen) zur Herstellung von Arzneimitteln zur Behandlung von Malaria |